Every minute counts: faster procedures, more patients, greater performance – with Chronos®

‍

Procedure frequency and ART requirements

‍
In Assisted Reproductive Technology (ART) centers, transvaginal ultrasound plays a central role in patient care. From the initial assessment to early pregnancy monitoring, each pathway — IVF, ICSI, simple stimulation, or frozen embryo transfer—involves multiple ultrasound exams. On average, a patient may undergo 4 to 7 ultrasounds throughout her journey.

‍

The risks associated with this specialty require absolute rigor in disinfection. In accordance with recommendations, a High-Level Disinfection (HLD) must be performed between each patient.

However, traditional chemical solutions have several limitations: handling time, potential residues, and complex consumable management.

‍

It is in this context that Chronos®, the UV-C disinfection system developed by Germitec, provides an innovative, reliable, and ART-adapted technological solution.

‍

Chemical-free, rapid, and reproducible disinfection

The Yuvee® technology integrated into Chronos® relies on the emission of UV-C radiation at 254 nm, known for its germicidal capacity.

This technology rapidly inactivates microbial DNA and RNA, providing validated disinfection against a broad spectrum of pathogens, including the most resistant, such as HPV and HIV.

‍

Each 90-second¹ cycle delivers High-Level Disinfection for compatible ultrasound probes² without the use of chemicals or intermediate rinsing.

‍

Less waiting, more patients, greater performance optimizing workflow and continuity of care

In an environment where consultations and oocyte retrievals occur at a fast pace, the speed of disinfection is a major asset. Chronos® enables near-immediate probe rotation between patients, reducing waiting times and ensuring continuity of the patient pathway.

‍

Disinfection with Chronos® integrates seamlessly into the workflow of an ART center, maintaining continuity across all procedures involving transvaginal ultrasound. This integration ensures both safety and smooth workflow, without any interruption of care.

‍

Published evidence indicates choosing UV systems over wipes, up to 6 additional patients per day can be accommodated.³

‍

This streamlined workflow improves the organization of the clinical and technical team and helps maintain optimal service dynamics. Additionally, eliminating chemical disinfectants simplifies logistics, while reducing handling, storage, and traceability constraints associated with traditional disinfectants.

‍

Using Chronos® ensures a high level of safety and continuous care without interruptions.

‍

A strategic advantage for ART centers

‍

Adopting Chronos® is an investment in a solution that is:

• Safe for patients and staff
• High-performing, thanks to patented UV-C technology
• Fast, improving workflow efficiency
• Eco-friendly, eliminating the need for chemicals
• Equipped with integrated traceability, ensuring full compliance

By offering reliable, rapid, and automated UV-C disinfection, Chronos® helps enhance quality and safety of care in ART, while optimizing team workflow and improving patient comfort.

‍

Conclusion

In the demanding ART environment, Chronos® establishes itself as a reference solution for transvaginal probe disinfection.

‍

Sources :

1. Internal data: cycle duration in about 90 seconds subject to reaching the pre-set UV-C dose validating the HLD cycle.
2. Chronos® is indicated for use in a healthcare environment to achieve aHigh-Level Disinfection of surfaces of external, transvaginal and transrectal ultrasound probes that do not contain lumens and that do not contain indentations or channels that are deeper than their widths.
3. Time-effectiveness and convenience of transvaginal ultrasound probe disinfection using ultraviolet vs chlorine dioxide multistep wipe system: prospective survey study C. KYRIACOU

‍